1369963-03-0

Basic information

• Product Name: methyl O-[(4-fluorophenyl)carbamoyl]-N-formyl-N-(4'-methylbiphenyl-4-yl)homoserinate
• Synonyms: methyl O-[(4-fluorophenyl)carbamoyl]-N-formyl-N-(4'-methylbiphenyl-4-yl)homoserinate
• CAS NO: 1369963-03-0
• Molecular Weight: 464.493
• Mol File: 1369963-03-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: methyl O-[(4-fluorophenyl)carbamoyl]-N-formyl-N-(4'-methylbiphenyl-4-yl)homoserinate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl O-[(4-fluorophenyl)carbamoyl]-N-formyl-N-(4'-methylbiphenyl-4-yl)homoserinate(1369963-03-0)
• EPA Substance Registry System: methyl O-[(4-fluorophenyl)carbamoyl]-N-formyl-N-(4'-methylbiphenyl-4-yl)homoserinate(1369963-03-0)

Safety Data

• Hazardous Substances Data: 1369963-03-0(Hazardous Substances Data)

Upstream product

• 1369963-00-7 N-(4'-methylbiphenyl-4-yl)-N-(2-oxotetrahydrofuran-3-yl)formamide 
• 1369962-99-1 3-[(4'-methylbiphenyl-4-yl)amino]dihydrofuran-2(3H)-one 
• 1204-78-0 4-(4-methylphenyl)aniline 
• 2143-88-6 4-nitro-4'-methyl-1,1'-biphenyl 
• 586-78-7 para-nitrophenyl bromide 
• 1369963-01-8 methyl N-formyl-N-(4'-methylbiphenyl-4-yl)homoserinate 
• 1195-45-5 para-fluorophenyl isocyanate 
• 5720-05-8 4-methylphenylboronic acid 

Downstream Products

• 1369961-86-3 O-[(4-fluorophenyl)carbamoyl]-N-formyl-N-(4'-methylbiphenyl-4-yl)homoserine 

Relevant articles and documents

MATRIX METALLOPROTEINASE INHIBITORS

The present invention relates to methyl sulfonamides and N-formamides derivatives of formula (I) and to processes for their syntheses. The invention also relates to pharmacological compositions containing these derivatives and methods of treating asthma, rheumatoid arthritis, COPD, rhinitis, osteoarthritis, psoriatie arthritis, psoriasis, pulmonary fibrosis, pulmonary inflammation, acute respiratory distress syndrome, perodontitis, multiple sclerosis, gingivitis, atherosclerosis, dry eye, neointimal proliferation which leads to restenosis and ischemic heart failure, stroke, renal disease, tumor metastasis, and other inflammatory disorders characterized by over expression and over activation of an matrix metalloproteinase using the compounds.